BY CHRISTOPHER DUE KARLSSON
-
Vecow Unveils Next-Gen Edge AI Server Platforms to Accelerate AI Development across Diverse Applications
POSTED 11/12/2024 Glossy Taipei Metropolis, Taiwan, Nov. 12, 2024 – Vecow Co., Ltd., a world team of embedded specialists, proudly introduces its next-abilities edge AI server platforms. Powered by Intel® Xeon® D Sequence, Intel® Xeon® Scalable processors, and AMD EPYC™ processors, this new lineup brings unmatched efficiency to AI, edge, and IoT functions. Edge servers
-
Same Sky Expands Absolute Encoder Line to Support Larger Shaft Sizes
Same Sky’s Motion and Adjust Neighborhood on the present time introduced the addition of a brand unique sequence to its modern AMT absolute encoder family designed to present a take to larger motor shaft sizes from 9 mm to 15.875 mm (5/8 chase). The AMT24 sequence, in line with Same Sky’s proprietary capacitive ASIC skills
-
The Bot Brief
POSTED 11/04/2024 “There will not be the sort of thing as a pressure on earth more extremely effective than a thought whose time has intention.” – Victor Hugo Bots in the Recordsdata: Despite a valuable selloff on the NASDAQ and a 1.36% pullback by the S & P 500, the Bot Index managed to push
-
Novo Nordisk on collaboration with Ascendis: “A way to differentiate”
The partnership permits Novo Nordisk to make use of Ascendis Pharma’s platform for the Danish group’s medication. Nevertheless, Novo Nordisk declines to reveal whether or not parti…
-
Coloplast CEO on US subsidy plans for billion-dollar acquisition: “No news is good news”
Coloplast’s administration anticipates its Icelandic procurement Kerecis to continue to be reimbursable in the United States.
-
Zealand Pharma CEO on possible partnership in the obesity market: “I promised myself not to say much”
Nonetheless, the president states that Zealand Pharma is going after a collaboration and not a permit arrangement for the possible weight reduction medicine petrelintide.
-
CEO stands by Coloplast Chair’s share sale, despite stock slump
chief executive officer Kristian Villumsen claims he’s totally great with Chairman Lars Rasmussen having actually marketed 94% of his Coloplast passion in September.
-
CEO stands by Coloplast Chair’s share sale, despite stock slump
CEO Kristian Villumsen says he’s completely fine with Chairman Lars Rasmussen having sold 94% of his Coloplast interest in September.
-
Humanoid development: torque-dense, efficient motors are essential | RoboticsTomorrow
Humanoid pattern: torque-dense, efficient motors are fundamental Humanoid robots, designed to operate in cessation interaction with folk, rely heavily on subtle and managed joint and limb motion. This makes the preference of the motors that energy the axes of motion serious. Alongside high torque density and responsiveness, effectivity to enable long battery life is key
-
Leo Pharma launches eczema cream in test of new strategy
According to the dermatology business’s chief executive officer, the launch is “a fundamental part” of the business’s brand-new exterior technology method.
